Results for tag: "Wolman Disease Drug"

The Wolman Disease Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It is a rare, inherited disorder that affects the body's ability to break down fats and cholesterol. Treatment for Wolman Disease is focused on managing symptoms and preventing complications. This includes dietary changes, enzyme replacement therapy, and other medications. Dietary changes are the primary treatment for Wolman Disease, as they help to reduce the amount of fat and cholesterol in the body. Enzyme replacement therapy is used to replace the missing enzyme in the body, allowing it to break down fats and cholesterol. Other medications may be prescribed to help manage symptoms and prevent complications. Some companies in the Wolman Disease Drug market include Sanofi, Pfizer, Novartis, and Shire. Show Less Read more